help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carey, R. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*HYDROCORTISONE

Journal of Clinical Endocrinology & Metabolism, Vol 54, 463-469, Copyright © 1982 by Endocrine Society


ARTICLES

Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin

RM Carey

To clarify whether dopaminergic inhibition of aldosterone secretion is physiologically dependent on stimuli from tropic hormones, we attempted to block angiotensin II (AII)- and ACTH-mediated increases in the plasma aldosterone concentration (PAC) with dopamine in normal human subjects. The effect of dopamine on metoclopramide-induced aldosterone secretion also was studied. Six normal male subjects in metabolic balance on a 150 meq/day sodium and 60 meq/day potassium intake received AII infusion at 2, 4, and 6 pmol/kg . min, each dose for 30 min, on each of 2 consecutive days. On the first day, the subjects received a vehicle infusion from 60 min before to the end of the AII infusion; on the second day, dopamine (4 micrograms/kg . min) was substituted for vehicle. AII in the presence of vehicle increased PAC from 5.4 +/- 1.3 to 19.9 +/- 2.9 ng/100 ml; AII in the presence of dopamine increased PAC from 4.8 +/- 0.5 to 19.5 +/- 1.8 ng/100 ml (P = NS). After an interval of 3 weeks on an ad libitum diet, the same protocol was repeated except that ACTH (5, 10, and 20 U/h) was substituted for AII. ACTH in the presence of vehicle increased PAC from 8.1 +/- 2.7 to 27.3 +/- 3.1 ng/100 ml; in the presence of dopamine, ACTH increased PAC from 4.7 +/- 0.5 to 34.9 +/- 6.1 ng/100 ml (P = NS). Metoclopramide increased PAC from 4.5 +/- 0.6 to 17.8 +/- 2.3 ng/100 ml in the presence of vehicle and from 4.4 +/- 0.5 to 7.2 +/- 0.7 ng/100 ml in the presence of dopamine (P less than 0.01). Dopamine did not decrease basal PAC. Dopamine inhibits increases in aldosterone secretion induced by dopamine antagonist but does not alter AII- or ACTH-induced steroid secretion. Acutely, dopaminergic inhibition of aldosterone secretion is independent of AII and ACTH.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K.-D. Wu, Y.-M. Chen, T.-S. Chu, S.-C. Chueh, M.-H. Wu, and H. Bor-Shen
Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4460 - 4467.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON
Dopamine Receptors: From Structure to Function
Physiol Rev, January 1, 1998; 78(1): 189 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society